Rapidly progressive glomerulonephritis in Goodpasture disease is mediated by autoantibodies binding to the non-collagenous NC1 domain of ␣3(IV) collagen in the glomerular basement membrane. Goodpasture epitopes in the native autoantigen are cryptic (sequestered) within the NC1 hexamers of the ␣3␣4␣5(IV) collagen network. The biochemical mechanism for crypticity and exposure for autoantibody binding is not known. We now report that crypticity is a feature of the quaternary structure of two distinct subsets of ␣3␣4␣5(IV) NC1 hexamers: autoantibody-reactive M-hexamers containing only monomer subunits and autoantibody-impenetrable D-hexamers composed of both dimer and monomer subunits. Goodpasture antibodies only breach the quaternary structure of M-hexamers, unmasking the cryptic epitopes, whereas Dhexamers are resistant to autoantibodies under native conditions. The epitopes of D-hexamers are structurally sequestered by dimer reinforcement of the quaternary complex, which represents a new molecular solution for conferring immunologic privilege to a potential autoantigen. Dissociation of non-reinforced M-␣3␣4␣5(IV) hexamers by Goodpasture antibodies is a novel mechanism whereby pathogenic autoantibodies gain access to cryptic B cell epitopes. These findings provide fundamental new insights into immune privilege and the molecular mechanisms underlying the pathogenesis of human autoimmune Goodpasture disease.
The refinement of immunological privilege has been a work in progress over a number of decades. Privilege originally implied a location anatomically protected from attack by the immune system, such as the eye, brain, or testes (1) . It is now recognized that the pathophysiology of protectiveness involves multiple mechanisms, including cytokines that inhibit innate or adaptive immunity (2) , systemic regulatory T cells (3) , and local cytotoxic mechanisms producing apoptosis of effector T cells induced by local FasL-Fas interactions (4) . What has not been widely appreciated is that the molecular sequestration of self-antigen in complex structures can be a critical mechanism of immunologic privilege. The autoantigen of Goodpasture (GP) 1 disease is a prototypic example. In GP disease, autoreactive B cells, with assistance from helper T cells, produce autoantibodies that bind to the glomerular basement membrane (GBM), causing rapidly progressive glomerulonephritis and renal failure (5) . GP autoantibodies passively transfer anti-GBM disease to monkeys or human kidney allografts (6) . These autoantibodies are directed against the ␣3 chain of collagen IV (7) and recognize two major conformational epitopes (E A and E B ) located within the carboxylterminal non-collagenous (NC1) domain (8, 9) . In the GBM, the ␣3(IV) chain associates specifically with the ␣4(IV) and ␣5(IV) chains (10, 11) to form a triple helical protomer. The ␣3␣4␣5(IV) protomers self-assemble into a network through end-to-end associations. At the carboxyl terminus, two protomers are linked head-to-head by interactions of their trimeric NC1 domains, forming a stable NC1 hexamer structure, which is the native form of the autoantigen targeted by GP antibodies. The NC1 hexamer complex can be excised from the insoluble collagen IV network by cleavage with collagenase for in vitro studies.
The GP epitopes are cryptic and structurally sequestered within the NC1 hexamer. Although a small amount of GP antibody can bind isolated NC1 hexamers under native conditions, maximal antibody binding requires unmasking of the cryptic epitopes. In tissue sections, this is achieved by pretreatment with acid urea (12) and in vitro by exposing hexamers to dissociating conditions (13, 14) . In vivo unmasking of the cryptic GP epitopes by putative pathogenic factors, such as oxidative stress (15) , is thought to be critical in the mechanism underlying the initiation of the disease.
The biochemical mechanism for the epitope crypticity remains an enigma, although some contributing factors have been described. Near the junction between the triple helical and NC1 domains, the quaternary structure of the NC1 hexamer hides a part of the E A epitope along a ridge adjacent to the ␣5NC1 domain, and the E B site is partly hidden along a ridge adjacent the ␣4NC1 domain (11) . Within the E A site, several residues critical for GP antibody binding have been identified (16, 17) . A homology-based model of the ␣3␣4␣5(IV) hexamer reveals that some GP epitope residues (Val-27, Gln-57) have restricted acces-* This work was supported by Grants P01 DK65123 (to D.-B. B.), R01 DK46282 (to E. G. N.), and R37 DK18381 (to B. G. H.) from the National Institutes of Health and by the Carl W. Gottschalk Research Scholar Award (to. D.-B. B.) from the American Society of Nephrology. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed: Div. sibility in the quaternary structure, which may prevent GP antibody binding to hexamers by steric hindrance (11) .
In the present study, we investigated the mechanism for sequestration of GP epitopes and how autoantibodies gain access to them. The results demonstrate that crypticity is a feature of the quaternary structure of two distinct subsets of ␣3␣4␣5(IV) NC1 hexamers, which differ in the degree of reinforced stabilization. GP antibodies selectively dissociated nonreinforced M-hexamers composed of monomer subunits only. In contrast, D-hexamers, reinforced by the presence of dimer subunits, were impenetrable by GP antibodies under native conditions. Sequestration of GP epitopes by structural reinforcement of D-hexamers represents a novel molecular mechanism for conferring immune privilege to a potential autoantigen.
EXPERIMENTAL PROCEDURES
Materials-Recombinant (r-) human ␣1 and ␣3 NC1 domains of type IV collagen were expressed in human embryonic kidney 293 cells and purified as described previously (8) . Human GBM was purified by detergent extraction from the renal cortex of pooled normal kidneys not used for transplantation (Midwest Organ Bank, Kansas City, KS). NC1 hexamers solubilized from the GBM by digestion with collagenase (Worthington, Lakewood, NJ) were purified by ion exchange on DE-52 and gel filtration on S-300 columns (11) . The NC1 monomer and dimer fractions of human and bovine GBM hexamers were separated by gel filtration after acid dissociation and reassociated into NC1 hexamers in vitro, as described previously (10) . Human GP IgG autoantibodies were affinity-purified from the sera or plasmapheresis fluid of patients with biopsy-proven anti-GBM disease, sequentially using immobilized protein G and human r-␣3NC1 monomers (14) . Normal human IgG and the non-GP IgG fraction of GP sera were used as negative controls. Use of human tissues and sera was approved by the Institutional Review Board at Vanderbilt University.
Enzyme-linked Immunosorbent Assay (ELISA)-GP sera or purified GP IgG antibodies were assayed by indirect ELISA as described previously (8) . A specific sandwich ELISA assay for ␣3NC1 domains was developed using immobilized GP IgGs as capture antibodies and ␣3NC1-specific mAbs as detection antibodies. The assay was performed in 96-well Maxisorp microtiter plastic plates coated overnight with affinity-purified human GP IgG (1 g/ml in carbonate buffer, pH 9.6) and blocked with 0.2% bovine albumin. Samples containing ␣3NC1 domains were diluted in incubation buffer (Tris-buffered saline, pH 7.4, with 1 mg/ml bovine albumin and 0.05% Tween 20) and allowed to bind to immobilized GP antibodies for 1 h at 37°C in duplicate wells. To unmask cryptic GP epitopes, some antigen samples were treated for 30 min with either acid (0.1 M glycine, pH 2.2) or 6 M guanidinium chloride (14) prior to the assay. The ␣3NC1 domains captured by immobilized GP antibodies were detected by sequential incubations with mAb EB3 (2 g/ml), alkaline phosphatase-conjugated anti-mouse IgG that had no cross-reactivity with human IgG (Rockland, Gilbertsville, PA), and chromogenic substrate (p-nitrophenol phosphate). Absorbance at 405 nm was measured with a Spectramax 190 plate reader (Molecular Devices, Sunnyvale, CA). The results represent the average of duplicate determinations, which differed by Ͻ5%. All experiments were repeated at least twice. Binding curves were obtained by non-linear regression by fitting the absorbance values (A) at various concentrations of antigen X to a single site binding model,
, where A max is the maximal binding and K d , the apparent dissociation constant, is the concentration of antigen at half-saturation. Comparisons between binding curves after various treatments were performed by global curve fitting, followed by F-test. Statistical analyses were performed using GraphPad Prism software, version 4.05.
Immunoprecipitation and Western Blotting-Affinity-purified GP IgG (ϳ10 g) was incubated with native GBM NC1 hexamers (5-10 g) in 200 l of Tris-buffered saline, pH 7.4, overnight at room temperature or for several days at 4°C. Dissociated NC1 subunits, prepared by treating hexamers with 6 M guanidinium chloride for 15 min at 60°C, were diluted at least 20-fold prior to incubation with GP IgG for ϳ1 h. Analysis of NC1 hexamers by immunoprecipitation with Mab3 (Wieslab AB, Lund, Sweden) was performed as described previously (10) . Antibody-antigen complexes were precipitated with protein G-agarose beads, solubilized in sample buffer, and analyzed by immunoblotting along with the unbound NC1 domains in supernatant. All samples were resolved into component NC1 monomers and dimers by sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) in replicate 4 -22% gradient gels under non-reducing conditions. After transfer to Immobilon P and blocking with casein, ␣1-␣5 NC1 domains were identified by immunoblotting with specific mAbs, as described previously (10, 11) .
Molecular Modeling and Graphic Representation-The molecular model for the (␣3␣4␣5) 2 NC1 hexamer is a full atom homology model built from the (␣1␣2␣1) 2 NC1 hexamer crystal structure, Protein Data Bank code 1M3D (18) , and optimized by a full atom molecular dynamics simulation using the NAMD software package (19) . 2 The GP IgG model is idealized from the crystal structure of an intact IgG; PDB code 1IGT (20) .
RESULTS
Validation of the Cryptic Nature of the GP Epitopes-The concept of cryptic GP epitopes is based on the observation that maximal binding of GP antibodies requires the dissociation of NC1 hexamers by protein denaturants (13) (14) (15) . In previous studies, this was usually assayed by indirect ELISA, comparing the binding of GP antibodies to GBM hexamers absorbed to a plastic solid phase with or without pretreatment with guanidinium chloride. However, pitfalls in this assay potentially undermine the concept of cryptic properties. First, immobilization of proteins by adsorption to the plastic surface of ELISA plates can alter the antigen conformation (21) , obscuring the features that confer autoantibody binding to native NC1 hexamers. Second, the heterogeneity of typical preparations of human GBM NC1 hexamers, containing ϳ15% ␣3␣4␣5 and ϳ84% ␣1␣2 hexamers (11), along with the cross-reactivity of GP antibodies toward ␣1NC1 domains, 3 introduces an ambiguity with regard to the identity of the antigen binding GP antibodies.
In the present study, both pitfalls were avoided using a capture ELISA for ␣3NC1 domains. In this assay, the soluble antigen (as recombinant NC1 monomers, native NC1 hexamers, or their subunits) was captured by affinity-purified GP IgG adsorbed onto a solid phase, and then GP-bound ␣3NC1 domains were specifically detected with mAbs reacting exclusively with ␣3NC1. Several anti-␣3NC1 mAbs were found to detect GP-bound ␣3NC1 domains specifically and sensitively (data not shown). For consistency, all experiments shown were performed using mAb EB3 (11) as the detecting antibody. The concentration dependence for the binding of human r-␣3NC1 monomers to purified GP antibodies from three different patients is shown in Fig. 1A . Half-saturation occurred at antigen concentrations ranging from 18 Ϯ 3 to 30 Ϯ 4 ng/ml (ϳ0.7-1.1 nM), indicating a very high affinity of interaction with the GP antibodies. Negative controls showed the absence of nonspecific interactions, demonstrating the specificity of the assay. Neither binding of r-␣3NC1 monomers to non-GP human IgG nor binding of r-␣1NC1 monomers to GP antibodies was detected ( Fig. 1, A and B) . Thus, capture ELISA provides a specific and sensitive assay for ␣3NC1 binding to GP antibodies, while preserving the native conformation of the antigen in solution.
Using the newly developed capture ELISA, the crypticity of ␣3NC1 epitopes in human GBM NC1 preparations containing a mixture of ␣1␣2 and ␣3␣4␣5 hexamers could be assayed without interference from ␣1NC1 (Fig. 1B) . The extent of ␣3NC1 binding to GP IgG was compared after reaction with native versus acid-treated NC1 hexamers. Similar results were obtained with four different GP antibodies. A relatively small amount of ␣3NC1 binding to GP IgG was consistently measured upon reaction with native NC1 hexamers (18 Ϯ 2%, relative to r-␣3NC1 positive control), which increased ϳ3-4-fold after acid-treatment of hexamers (to 60 Ϯ 8%; p Ͻ 0.001). This increase in antigen binding reflects the exposure of ␣3NC1 cryptic epitopes, likely caused by the disruption of the hexamer quaternary structure under dissociative conditions. However, it is not known whether the concomitant disruption of the secondary/tertiary structure of dissociated subunits also plays a role in unmasking the GP epitopes. This was addressed next.
The crypticity of GP Epitopes Depends on the Antigen Quaternary Structure-To determine whether dissociating conditions unmask GP epitopes by inducing changes in the antigen secondary/tertiary structure, the binding to GP IgG of human r-␣3NC1 monomers (expressed in mammalian cells for native folding) was compared, with and without acid-treatment ( Fig.  2A) . The binding of r-␣3NC1 monomers to GP IgG was slightly decreased after acid treatment, shifting the binding curve toward higher concentrations of antigen, equivalent to a 25% increase in the apparent K d (from 17.1 Ϯ 0.9 to 21.6 Ϯ 2 ng/ml; p ϭ 0.005). A comparable decrease in reactivity was produced by treatment of ␣3NC1 monomers with 3 M guanidinium chloride. Thus, dissociating conditions slightly degrade the binding capacity, demonstrating that the GP epitopes are not cryptic in the ␣3NC1 monomers.
In contrast to ␣3NC1 monomers, exposure of NC1 hexamers to dissociating conditions caused a dramatic increase in binding to GP antibodies (Fig. 2B) . The overall effect was a large shift of the binding curves toward lower antigen concentrations, equivalent to an 8-fold decrease in the apparent K d after acid treatment and a 10.6-fold decrease after guanidinium treatment (p Ͻ 0.0001). Overall, these findings show that the GP epitopes are cryptic only in ␣3␣4␣5 NC1 hexamers but not in ␣3NC1 monomers, thus demonstrating that their crypticity is dependent on the quaternary structure of the autoantigen.
Two Subsets of (␣3␣4␣5) 2 NC1 Hexamers Have Distinct Reactivities toward GP Antibodies-The small amount of binding under native conditions and the 8 -10-fold enhancement of binding after dissociation suggested the existence of two distinct subsets of ␣3␣4␣5 NC1 hexamers: reactive hexamers that bind GP antibodies under native conditions and impenetrable hexamers that do not react unless dissociated into subunits. This hypothesis was tested by immunoprecipitating human GBM hexamers with purified GP antibodies under native conditions. The GP-bound fraction, absorbed to protein G beads (the immunoprecipitate), corresponds to the subset of reactive ␣3␣4␣5-hexamers that bind GP antibodies under native conditions (Fig. 2B, open circles) . In contrast, the GP-unbound fraction (the supernatant) consisted of ␣3␣4␣5-hexamers that were impenetrable by GP antibodies under native conditions (Fig.  2C, open circles) . In impenetrable hexamers, the GP epitopes were fully sequestered and inert toward GP antibodies, until the quaternary structure was disrupted by dissociating conditions (Fig. 2C, closed circles) .
Subunit Composition of GP-reactive Hexamers-To explore the structural basis for the different reactivity toward GP antibodies of the two subsets of ␣3␣4␣5 NC1 hexamers, their subunit composition was determined. The GP-bound and -unbound fractions were analyzed by SDS-PAGE and immunoblotting with mAbs specific for ␣1-␣5 NC1 domains. The reference sample, total GBM hexamers (Fig. 3A) , contained ␣1 and ␣2 NC1 monomers and homodimers (derived from (␣1␣2␣1) 2 NC1 hexamers) along with ␣3, ␣4, and ␣5 monomers and ␣3/␣5 and ␣4/␣4 dimers (derived from (␣3␣4␣5) 2 NC1 hexamers), as previously reported (11) .
After the reaction of GBM hexamers with GP antibodies under native conditions, the GP-bound fraction was composed of ␣3 and ␣4 NC1 monomers but was devoid of ␣5NC1 monomers, ␣4-␣4, and ␣3-␣5 NC1 dimers (Fig. 3B) . The same results were obtained with affinity-purified GP antibodies from three other patient sera (data not shown). Co-precipitation of ␣4NC1 monomers was due to their non-covalent association with ␣3NC1 monomers, because GP antibodies did not bind to purified ␣4NC1 monomers (data not shown). Because ␣3 and FIG. 1. A specific capture ELISA assay for ␣3NC1 binding to GP antibodies. A, binding of r-␣3NC1 monomers to immobilized GP antibodies affinity-purified from three patient sera (filled circles) or to normal human IgG (open circles) used as a negative control was measured by capture ELISA using anti-␣3NC1 mAb EB3 as the detecting antibody. B, the crypticity of GP epitopes was assayed by capture ELISA by comparing the binding of native versus dissociated human GBM hexamers (500 ng/well) to four different GP antibodies (crosshatched bars). There was no binding to normal human IgG (solid bars). Recombinant ␣3NC1 monomers (50 ng/well) were used as positive controls and an excess of r-␣1NC1 monomers (500 ng/well) as negative controls.
FIG. 2. Dissociating agents unmask cryptic GP epitopes on
␣3␣4␣5NC1 hexamers but not on ␣3NC1 monomers. Binding of r-␣3NC1 monomers (A), untreated GBM hexamers (B), and GBM hexamers preabsorbed with GP antibodies (C) to immobilized GP antibodies was measured by capture ELISA. GP-absorbed hexamers (C) were prepared by incubating GBM hexamers overnight with an excess of purified GP antibodies under native conditions and then removing the immune complexes using immobilized protein G. Binding curves were compared for native, untreated antigens (open symbols) versus antigens exposed to dissociating conditions (gray symbols, 6 M guanidinium hydrochloride; filled symbols, 0.1 M glycine, pH 2.2). Arrows indicate an increase or a decrease in GP reactivity induced by dissociating agents.
␣4NC1 monomers only form hexamers together with ␣5NC1 monomers (10), we investigated whether the binding of GP antibodies caused the release of free ␣5NC1 subunits. This was verified using mAb H52 (22) , which recognizes a cryptic epitope within the ␣5NC1 domain and binds only to isolated ␣5NC1 monomer and dimer subunits (Fig. 4A, lane b) but not to intact hexamers (Fig. 4A, lane a) . Importantly, immunoprecipitation with mAb H52 revealed the presence of free ␣5NC1 monomers (but not ␣5NC1 dimers) in the GP-unbound supernatant from the reaction of GBM hexamers with GP antibodies (Fig. 4A,  lane c) . Because mAb H52 could not react with ␣5NC1 from intact hexamers, the ␣5NC1 monomers it precipitated from the GP-supernatant could only have been produced by the dissociation of GP-reactive hexamers upon antibody binding to ␣3/ ␣4NC1 monomers (Fig. 4B) . Therefore, the subset of GP-reactive hexamers was originally composed of ␣3, ␣4, and ␣5NC1 monomers but was devoid of dimer subunits (henceforth designated as M-␣3␣4␣5 hexamers). Thus, under native conditions, GP antibodies reacted with M-␣3␣4␣5 hexamers with dissociation of the quaternary complex. The interactions between the ␣3 and ␣5 monomers were disrupted upon antibody binding, whereas those between the ␣3 and ␣4 monomers were retained.
Subunit Composition of GP-impenetrable Hexamers-In contrast to the GP-reactive fraction, the GP-unbound fraction containing impenetrable hexamers comprised all subunits present in the control sample, including ␣3, ␣4, and ␣5NC1 monomers, ␣3-␣5 NC1 heterodimers, and ␣4-␣4 NC1 homodimers. Analysis of this fraction by immunoprecipitation with Mab3 (Fig.  3D) , which recognizes a non-cryptic epitope on ␣3NC1 (17, 23) , produced the same profile previously reported for total GBM hexamers (10) . Therefore, the impenetrable hexamers were composed of ␣3NC1 monomers and dimers co-existing with ␣4 and ␣5NC1 monomers and dimers. Judging from the intensity of staining, the relative proportion of NC1 monomers to dimers was reduced in the GP-impenetrable hexamers, compared with control GBM hexamers. The GP-impenetrable hexamers were designated as D-␣3␣4␣5 hexamers, because they were distinguished from M-hexamers by the presence of ␣3, ␣4, and ␣5 NC1 dimers in addition to ␣3, ␣4, and ␣5 NC1 monomers.
Disruption of the Quaternary Hexamer Structure by Low pH Renders All ␣3NC1 Subunits Reactive with GP Antibodies-
Upon exposure to low pH, the impenetrable D-␣3␣4␣5 hexamers dissociate, allowing GP antibodies to bind to ␣3NC1 dimer and monomer subunits. Immunoprecipitation of acid-dissociated hexamers by GP antibodies yielded ␣3-␣5 and ␣4-␣4 NC1 dimers along with ␣3 and ␣4 NC1 monomers (Fig. 3E) . The ␣3 NC1 monomer and ␣3-␣5 NC1 dimer subunits of dissociated hexamers were completely precipitated by GP antibodies, because they were not detected in the GP-unbound supernatant (Fig. 3F) . In contrast, ␣4NC1 monomers and homodimers were present in both the immunoprecipitate and the unbound fraction, suggesting a reversible association with ␣3NC1 subunits, whereas ␣5NC1 monomers were present exclusively in the unbound fraction. The absence of ␣5NC1 monomers from the GP-bound fraction further confirms that the binding of GP antibodies to ␣3NC1 subunits disrupts the ␣3/␣5 interactions, as found for the M-␣3␣4␣5 hexamers. These findings imply that, within the intact D-␣3␣4␣5 hexamers, the epitopes of ␣3NC1 monomer and dimer subunits are totally inaccessible for binding GP antibodies, whereas after epitope unmasking by hexamer dissociation by low pH, both the ␣3NC1 monomer and dimer subunits can bind GP antibodies. Importantly, this indicates that ␣3-␣5 NC1 dimers are impenetrable toward GP antibodies only in the context of an NC1 hexamer complex but not as isolated NC1 subunits. Thus, within the D-␣3␣4␣5 hexamers, the presence of dimers rendered the GP epitopes of ␣3NC1 subunits inaccessible for antibody binding.
Overall, these findings reveal a distinction between the qua-
FIG. 3. Subunit composition of GP-bound and GP-unbound fractions of human GBM hexamers. NC1 hexamers from human GBM (a) were incubated with GP antibodies under native conditions (left) or after acid dissociation (right). The GP-bound fractions from native (b) or dissociated (e) hexamers were precipitated with protein G beads and resolved by SDS-PAGE into monomer (M) and dimer (D)
subunits, the identity of which was established by Western blot. For each sample, five replicate strips were individually stained with chainspecific mAbs against the ␣1-␣5 NC1 domains. The supernatants containing the GP-unbound fractions from native (c) and dissociated (f) hexamers were analyzed in parallel. The GP-unbound fraction from native hexamers (c) was further analyzed by immunoprecipitation with Mab3 (d), which binds to NC1 hexamers containing ␣3NC1 subunits.
FIG. 4. Binding of GP antibodies to reactive GBM hexamers releases free ␣5NC1 monomers.
A, native human GBM hexamers (a), hexamer subunits produced by hexamer dissociation with 6 M guanidine hydrochloride for 15 min at 60°C (b), and the GP-unbound fraction (GP sup., the supernatant) from the reaction of GP antibodies (ϩGP Ab) with native hexamers (c) were immunoprecipitated with rat mAb H52 recognizing a cryptic epitope on the ␣5NC1 domains. The presence of ␣5NC1 domains in the H52-precipitated fractions was determined by Western blot using an anti-␣5NC1 mouse mAb, Mab5. B, because native NC1 hexamers do not react with mAb H52, precipitation of ␣5NC1 monomers by H52 from the GP-unbound supernatant indicates the presence of free ␣5NC1 monomers, which must have been dissociated by GP antibodies binding to hexamers composed of ␣3, ␣4, and ␣5NC1 monomers.
ternary structures of the two hexamer subsets. One subset, composed of monomer subunits only (M-␣3␣4␣5 hexamers), binds GP antibodies under native conditions causing dissociation of subunits. The other subset is composed of dimer and monomer subunits (D-␣3␣4␣5 hexamers) and is impenetrable toward GP antibodies unless dissociated into subunits by low pH or protein denaturant. The findings also reveal the ability of GP antibodies to disrupt the quaternary structure of M-␣3␣4␣5 hexamers, causing dissociation into subunits and unmasking of epitopes, but not of D-␣3␣4␣5 hexamers, indicating that the NC1 dimer subunits (␣3-␣5 heterodimers and ␣4-␣4 homodimers) prevent the antibody-induced dissociation of hexamers.
Verification of the Two Hexamer Subsets and Their Distinct
Binding to GP Antibodies-Using reconstituted M-␣3␣4␣5 and D-␣3␣4␣5 hexamers, the properties of the two hexamer subsets were further investigated with regard to their reactivity with GP antibodies. We have previously shown that homologous M-␣1␣2 and D-␣1␣2 hexamers can each be reconstituted from monomer and dimer subunits that were isolated from acid dissociation of native ␣1␣2 hexamers (24) . In the present study, this strategy was used to produce in vitro reconstituted M-␣3␣4␣5 hexamers from NC1 monomer subunits and D-␣3␣4␣5 hexamers from NC1 dimer subunits of human GBM. The composition of reconstituted hexamers was verified by Western blot (Fig. 5A) , confirming that reassociated M-␣3␣4␣5 hexamers contained ␣3, ␣4, and ␣5 monomer subunits only and reassociated D-␣3␣4␣5 hexamers contained ␣3, ␣4, and ␣5 dimer subunits only.
The GP antibody reactivity of isolated GBM monomers (due to ␣3NC1 monomers) was substantially reduced (but not completely abolished) upon reconstitution into M-␣3␣4␣5 hexamers, indicating that GP epitopes become less accessible in M-hexamers. The restricted accessibility of GP epitopes within the quaternary structure was confirmed by a 3-fold increase in binding to GP IgG after acid dissociation of reconstituted Mhexamers (Fig. 5B) . In contrast, the GP antibody reactivity of isolated GBM dimers (due to ␣3-␣5 NC1 dimers) was totally abolished upon assembly into D-␣3␣4␣5 hexamers, indicating that GP epitopes became completely inaccessible (cryptic) under native conditions within the reinforced quaternary structure (Fig. 5C) . Redissociation of D-hexamers restored reactivity with GP antibodies. Overall, the reconstitution studies verified that: a) ␣3, ␣4, and ␣5 NC1 monomers can assemble into M-hexamers, whereas ␣3-␣5 and ␣4-␣4 NC1 dimers can assemble into D-hexamers; and b) under native conditions, M-hexamers can still bind GP antibodies, but D-hexamers are impenetrable unless first dissociated by denaturing conditions. Therefore, NC1 dimers render the cryptic epitopes of D-hexamers totally inaccessible for binding GP antibodies.
The relative increase in GP reactivity of reconstituted Mand D-hexamers after acid dissociation permitted an estimation of the relative proportion of M-and D-hexamers in the human GBM preparation. The GP reactivity of native human GBM hexamers, solely due to native M-hexamers, was ϳ10% relative to their isolated subunits (Fig. 2B) . Dissociated Mhexamers were 3-fold more reactive than native M-hexamers (Fig. 5B) , thereby accounting for ϳ30% of the overall GP reactivity of dissociated GBM hexamers. Thus, the balance of ϳ70% of total GP reactivity was due to ␣3NC1 subunits of impenetrable D-hexamers, rendered reactive by dissociation. Therefore, a relatively small fraction of ␣3(IV) collagen exists in the GBM in a form that can be targeted by GP antibodies, and a majority occurs as impenetrable complexes not reactive with antibodies.
Verification of the Capacity of GP Antibodies to Dissociate M-hexamers but Not D-hexamers-The capacity of GP antibodies to dissociate M-␣3␣4␣5 hexamers but not D-␣3␣4␣5 hexamers was further investigated by immunoprecipitation of reconstituted M-␣3␣4␣5 and D-␣3␣4␣5 hexamers. The reconstituted hexamers (Fig. 6) were prepared from NC1 monomers and dimers isolated from the bovine GBM because of the very limited availability of human GBM. Bovine GBM hexamers, which can be prepared in large quantities, have been well characterized and shown to be similar to human GBM hexamers with regard to subunit organization (10) and cryptic properties of the GP epitopes (13) . The reconstituted M-␣3␣4␣5 hexamers (Fig. 6, a) were analyzed with Mab3 antibody, which binds to ␣3NC1 subunits, but co-precipitated the ␣4 and ␣5 NC1 monomers along with ␣3NC1 monomers (Fig. 6, b) , indicating that the ␣3, ␣4, and ␣5 NC1 domains occurred together in the reconstituted M-hexamers. Likewise, within the reconstituted D-␣3␣4␣5 hexamers (Fig. 6, e) , ␣3-␣5 heterodimers occurred together with the ␣4-␣4 homodimers (Fig. 6, f) . Under native conditions, M-hexamers reacted with GP antibodies, which bound to the ␣3/␣4 NC1 monomer complex, although displacing ␣5NC1 monomers (Fig. 6, c) ; this confirms the pattern of binding observed for native M-␣3␣4␣5 hexamers from human GBM. In sharp contrast, reconstituted D-hexamers did not bind GP antibodies under native conditions (Fig. 6, g) , although a complex of ␣3-␣5 and ␣4-␣4 NC1 dimers bound to GP IgG after dissociation (Fig. 6, h) . Together, these findings verify the capacity of GP antibodies to dissociate M-␣3␣4␣5 hexamers and unmask GP epitopes for binding by displacing ␣5NC1 monomers, although retaining the interaction between the ␣3NC1 and ␣4NC1 monomers. Moreover, these findings demonstrate that the impenetrability of D-␣3␣4␣5 hexamers to GP antibodies is because of the dimer subunits, which stabilize the quaternary structure and prevent hexamer dissociation by GP antibodies.
DISCUSSION
This study identified several novel features of the biochemical mechanisms underlying epitope crypticity and how GP antibodies bind to native NC1 hexamers of collagen IV. First, a newly developed specific capture ELISA provided a strategy to validate the cryptic properties of GP epitopes and to ascertain that their crypticity is dependent on the hexamer quaternary structure. Second, the difference in binding capacity under native and dissociative conditions revealed the existence of two distinct subsets of hexamers differing in quaternary structure: a) reactive M-␣3␣4␣5 hexamers, composed of NC1 monomer subunits only, which bind GP antibodies under native conditions; and b) impenetrable D-␣3␣4␣5 hexamers, composed of dimer and monomer subunits, which do not bind autoantibodies unless dissociated into subunits by low pH or protein denaturants. Third, the disruption of the interactions between ␣3 and ␣5NC1 monomer subunits demonstrated the capacity of GP antibodies to selectively dissociate M-␣3␣4␣5 hexamers (but not D-␣3␣4␣5 hexamers), unmasking cryptic epitopes in the ␣3NC1 subunit. Finally, the impenetrability of D-␣3␣4␣5 hexamers for GP antibodies under native conditions, contrasted with the reactivity of M-␣3␣4␣5 hexamers, suggests that resistance to dissociation by GP antibodies is due to NC1 dimers stabilizing the hexamer quaternary structure. Together, these findings provide the foundation for a new paradigm for the mechanism of immune privilege in the natively occurring GP autoantigen and its interaction with autoantibodies (Fig. 7) .
The characteristic feature of D-hexamers is the presence of NC1 dimer subunits resistant to dissociation by denaturing agents or SDS-PAGE. The stabilizing event associated with the formation of non-dissociable NC1 dimers is necessary to render the D-hexamers impenetrable by GP antibodies, with potential hexamers lacking reinforcement reacts with GP antibodies (GP anti-␣3) with concomitant disruption of the quaternary structure. One possible mechanism of reaction is illustrated. In NC1 hexamers, certain epitope residues in the E A region (yellow) of the ␣3 NC1 subunits (red) are masked by the proximity to ␣5 NC1 subunits (green), whereas other residues are accessible and may initially bind autoantibodies with lower affinity. An antibody-induced conformational change in the ␣3NC1 could then cause the dissociation of ␣5NC1 monomers, completely unmasking the E A epitope and allowing unrestricted high-affinity binding of autoantibodies to ␣3NC1 monomers. Alternatively, autoantibodies may competitively displace ␣5NC1 subunits, because they have higher affinity for ␣3NC1 reaching the same final state. In contrast, the subset of reinforced D-␣3␣4␣5 hexamers is impenetrable to GP antibodies under native conditions. The putative site of cross-link, proposed to involve Met-93 and Lys-211 (or Hyl-211) by analogy to D-␣1␣2␣1 hexamers, is represented by white ellipses at the NC1 trimer-trimer interface of the reinforced hexamer. This reinforcement represents a novel molecular mechanism of immune privilege for potential autoantigens. This figure was produced by J. P. Cartailler of Symmation LLC (Nashville, TN).
impact on both the etiology and the pathogenesis of the syndrome. In the absence of this structural reinforcement, the formation of the M-␣3␣4␣5 NC1 hexamer complex brings the GP epitopes in close proximity to ␣4 and ␣5NC1 domains and limits their accessibility but is not sufficient to avert reaction with GP antibodies. These findings establish the structural reinforcement of the quaternary structure as a novel molecular mechanism of immune privilege for potential autoantigens.
The nature of the molecular interactions underpinning the formation of NC1 dimers has been extensively studied in the homologous (␣1␣2␣1) 2 hexamers, but the detailed mechanism remains unknown. A subset of M-␣1␣2␣1 hexamers composed of ␣1 and ␣2 NC1 monomers exists in the bovine lens capsule basement membrane, and dimer-rich D-␣1␣2␣1 hexamers are predominant in the placenta basement membrane (24) . The x-ray structures of M-and D-␣1␣2␣1 hexamers (18, 25) disproved the long held view that NC1 dimers were generated by an interchain disulfide exchange. A novel thioether cross-link between the opposing Met-93 and Lys-211 at the NC1 trimertrimer interface was proposed based on the 1.9-Å x-ray crystal structure of D-␣1␣1␣2 from placenta basement membrane (25), but no cross-links were found at a higher resolution of 1.5 Å (24). However, the comparative analysis of their NC1 monomer and dimer subunits by trypsin digestion followed by mass spectrometry and Edman degradation is consistent with a crosslink between Met-93 and a Lys-211 post-translationally modified to hydroxylysine (35) . Analogous interactions (Fig. 7, white  ellipses) at the trimer-trimer interface of reinforced hexamers may play a key role in the structural reinforcement of D-␣3␣4␣5 hexamers.
Within the GBM, only the subset of M-␣3␣4␣5 NC1 hexamers lacking reinforcement of the quaternary structure has the propensity to react with circulating GP autoantibodies under native conditions. Disruption of the quaternary structure upon autoantibody binding provides a mechanism whereby pathogenic antibodies can gain access to cryptic epitopes under native conditions. The GP antibodies unmask cryptic epitopes on the ␣3NC1 monomer by displacing the ␣5NC1 subunit, although leaving the ␣3NC1 monomer in complex with the ␣4NC1 monomer. Selective dissociation of ␣5 (but not of ␣4NC1) monomers from susceptible hexamers implicates the immunodominant E A epitope (14) as both the culprit as well as the victim. Our results are consistent with exposure of the E A epitope, because it is located near the junction of the ␣3 and ␣5NC1 monomers within a hexamer structure and is inaccessible for binding when bound to the ␣5NC1 monomer (11) . In contrast, the E B epitope is located near the junction of the ␣3 and ␣4NC1 monomers and is inaccessible when ␣3NC1 is bound to the ␣4NC1 monomer. Thus, the findings implicate the immunodominant GP A antibodies targeting the E A epitope (8) in the dissociation event. This may provide a rationale for the observation that the prognosis for kidney survival is inversely correlated with titers of GP A but not of GP B antibodies (9) .
In conclusion, our findings provide new insights into the pathogenic mechanisms of GP disease. Although ␣3(IV) collagen is present in the thymus and available for induction of T cell tolerance (26) , autoreactive T cells still escape elimination and circulate (27) . The crypticity of the GP epitopes in tissue basement membranes makes it unlikely, however, that autoreactive T cells in the peripheral immune system will expand without an external precipitating event. Putative pathogenic factors include exposure to solvents (28, 29) , inhaled smoke (30) , or endogenous reactive oxygen species (15) . Decondensation of ␣3␣4␣5 hexamers by non-immune mechanisms in a host expressing immune susceptibility genes (31, 32) might activate residual auto-reactive helper T cells that expand the B cell repertoire against GP epitopes encoded by the ␣3(IV) collagen chain (5). Our results suggest that GP antibodies could further damage the GBM by accelerating epitope exposure. Circulating GP antibodies would readily target newly synthesized ␣3␣4␣5(IV) collagen protomers in the GBM before the structural stabilization of the hexamers could occur, thus perpetuating the inflammatory response. This may explain the therapeutic effect of plasmapheresis, whereby removal of circulating autoantibodies would break this vicious circle, facilitating GBM repair.
Differences among individuals in the ␣3NC1 monomer/dimer ratio in kidneys and lungs may also account for the variability in lung hemorrhage associated with glomerulonephritis. By Western blot, although ␣3NC1 monomer subunits are uniformly present and relatively constant in the human GBM from different individuals, they are frequently not found in the lung alveolar basement membranes (33) . The absence of ␣3NC1 monomers (implying an absence of GP-reactive M-␣3␣4␣5 hexamers) in the lungs of some patients may explain the phenotype of anti-GBM disease without pulmonary hemorrhage. Finally, the well recognized difficulty in inducing anti-GBM disease in mice may be related to the relative impenetrability of their GBM hexamers, which in turn is determined by the higher content of ␣3NC1 dimers in the murine GBM compared with that found in the human kidneys (34) .
